Albumin (Protein Electrophoresis) Test

If you have ever had a routine blood panel come back normal while you still felt something was off, this test offers a deeper look. Albumin (Protein Electrophoresis) does not just tell you how much albumin is in your blood. It shows you the shape and proportion of albumin relative to every other major protein group, revealing patterns that point to liver stress, chronic inflammation, immune deficiency, or even early blood cancers that a simple albumin number cannot detect.

Your liver makes albumin, and it is the single most abundant protein in your bloodstream. On a serum protein electrophoresis (SPE) report, albumin appears as the tallest, sharpest peak. When that peak shrinks, flattens, splits, or shifts relative to the other protein bands (called globulins), it tells a specific story about what is happening inside your body.

What This Test Actually Measures

Serum protein electrophoresis separates your blood proteins by electrical charge, then displays them as a series of peaks on a graph. Albumin is the dominant peak at the front of the pattern, normally making up about 50 to 65% of total serum protein. The remaining peaks represent groups of globulins: alpha-1, alpha-2, beta, and gamma fractions. Each fraction reflects different immune, inflammatory, and transport proteins.

A standard albumin blood test gives you a single concentration number. This test gives you that number in context: the shape of the albumin peak itself, the ratio of albumin to all globulins (called the A/G ratio, or albumin to globulin ratio), and whether any unexpected bands or distortions appear. That pattern information is what makes electrophoresis uniquely valuable for spotting problems a routine panel misses.

Heart Disease and Cardiovascular Risk

Low albumin is consistently linked to worse cardiovascular outcomes. In people with heart failure where the heart still pumps normally (called preserved ejection fraction), lower albumin levels are associated with more scarring in the heart muscle, stiffer arteries, and a higher chance of hospitalization or death. Albumin's cell-protecting and anti-clotting properties mean that when levels drop, those protective functions diminish too.

After an ischemic stroke (one caused by a blocked blood vessel in the brain), albumin levels at or below 3.4 g/dL are tied to greater disability and a higher chance of early cardiovascular events. A study that matched similar patients for comparison across over 500,000 stroke cases confirmed that low albumin independently predicts death and cardiovascular complications in the weeks following a stroke.

Critical Illness and Sepsis

In intensive care settings, albumin below about 3.0 g/dL independently increases the risk of dying in the hospital. In severe sepsis specifically, albumin below roughly 2.9 g/dL predicts higher 28-day mortality regardless of other severity scores. A study tracking nearly 2,000 sepsis patients in the ICU found that those whose albumin stayed persistently low had the worst outcomes, while those whose levels climbed over time did the best.

What matters is not just a single reading but the direction your albumin is heading. Patients whose albumin falls during a hospital stay face sharply worse odds than those whose levels stabilize or rise, even if both groups start at similar levels.

Liver and Kidney Disease

Because your liver is the only organ that makes albumin, a falling albumin fraction on electrophoresis can be an early signal that your liver's production capacity is declining. In cirrhosis (severe liver scarring), low albumin is part of the pattern that signals the liver is losing its ability to function. In kidney disease, particularly nephrotic syndrome (a condition where damaged kidneys leak large amounts of protein into the urine), albumin leaks out of the blood, pulling down levels. In acute kidney injury, low serum albumin independently predicts one-year mortality.

Cancer and Immune Function

In multiple cancers treated with immune checkpoint inhibitors (drugs that help the immune system fight tumors), lower baseline albumin consistently predicts worse overall survival and faster disease progression. Beyond cancer itself, the globulin fractions on electrophoresis can reveal abnormal immune protein production. A shrunken gamma globulin band can flag antibody deficiency, while an unexpected sharp spike in the gamma region may signal a monoclonal gammopathy, a condition where a single clone of immune cells produces an abnormal protein, sometimes a precursor to blood cancers like multiple myeloma.

This dual capability, spotting both low immune function and abnormal immune protein production, is what makes the full electrophoresis panel more informative than albumin alone.

Reference Ranges

Reference ranges for the albumin fraction on protein electrophoresis vary by lab method, population, and the specific electrophoresis platform used. The values below come from published research and are meant as orientation, not universal targets. Always compare your results within the same lab over time for the most meaningful trend.

A large observational study of over 100,000 patients found that albumin reference intervals should ideally be stratified by age and sex, as levels naturally decline with aging. In community-dwelling older adults, albumin at or above 4.4 g/dL was associated with the best survival outcomes. In surgical patients, albumin below 3.4 g/dL roughly doubled the odds of death within 30 days. In adolescents on hemodialysis, levels above 4.0 g/dL were tied to a 57% lower risk of death.

When Results Can Be Misleading

The method your lab uses to measure albumin matters more than most people realize. Bromocresol green (BCG), a common dye-based method, systematically overestimates albumin compared to more accurate techniques like bromocresol purple (BCP), capillary electrophoresis, and immunoassay. If your lab uses BCG, your albumin number may look reassuringly normal when a more precise method would show it is low. This is particularly relevant in kidney disease, where BCG-based overestimation can mask true protein-energy wasting.

In people with monoclonal gammopathies (conditions where an abnormal immune protein accumulates), the monoclonal protein spike on electrophoresis can distort the albumin measurement. Agarose gel electrophoresis tends to overestimate albumin when the monoclonal spike is large, because the two proteins overlap and confuse the software that reads the pattern.

• Acute illness or infection: Any significant inflammation temporarily suppresses albumin production and increases leakage from blood vessels, dropping your reading for days to weeks after the event.
• Dehydration or overhydration: Concentrated blood from dehydration can falsely raise albumin; excess fluid dilutes it.
• Recent surgery or trauma: Your body's inflammatory response to surgery drives albumin down for one to two weeks, making a post-surgical reading unreliable for baseline purposes.
• Lab method differences: BCG overestimates albumin; BCP and capillary electrophoresis are more accurate. Ask your lab which method they use if your results seem inconsistent.

Tracking Your Trend

A single albumin reading is a snapshot. What you really want is a trajectory. In sepsis patients, a falling albumin trend predicted worse outcomes more reliably than any single measurement. In community-dwelling older adults, albumin levels below 3.5 g/dL at baseline predicted higher rates of hospitalization and death regardless of pre-existing disease, but the trend over time added even more predictive power.

Get a baseline reading, then retest in three to six months if you are making health changes or managing a chronic condition. After that, at least annually. If your albumin fraction is dropping while your globulin fractions are rising, that pattern deserves investigation even if every individual number is still within the normal range. Use the same lab each time so the method stays consistent.

What to Do With Your Results

If your albumin fraction is low or falling, the next step depends on the pattern. A low albumin with elevated alpha-1 and alpha-2 globulin fractions suggests active inflammation. Pair this with hs-CRP (high-sensitivity C-reactive protein) to confirm. A low albumin with a shrunken gamma fraction raises concern about antibody deficiency and should prompt measurement of specific antibody levels (IgG, IgA, IgM). A sharp, narrow spike in the gamma or beta region may indicate a monoclonal gammopathy and warrants immunofixation electrophoresis, a follow-up test that identifies the exact type of abnormal protein.

If albumin is low alongside signs of liver stress (elevated liver enzymes, abnormal bilirubin), a hepatologist or gastroenterologist can help sort out whether the liver is the primary driver. If kidney protein loss is suspected, a urine albumin-to-creatinine ratio will clarify whether albumin is leaking through the kidneys. In most cases, the albumin fraction on electrophoresis does not give you a final diagnosis by itself, but it tells you exactly which follow-up tests to order and which specialist to see.